BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1955 related articles for article (PubMed ID: 16212428)

  • 1. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
    Yu KH; Rustgi AK; Blair IA
    J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic identification of serum biomarkers for gastric cancer using multi-dimensional liquid chromatography and 2D differential gel electrophoresis.
    Liu W; Liu B; Cai Q; Li J; Chen X; Zhu Z
    Clin Chim Acta; 2012 Jul; 413(13-14):1098-106. PubMed ID: 22446497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient prefractionation of low-abundance proteins in human plasma and construction of a two-dimensional map.
    Cho SY; Lee EY; Lee JS; Kim HY; Park JM; Kwon MS; Park YK; Lee HJ; Kang MJ; Kim JY; Yoo JS; Park SJ; Cho JW; Kim HS; Paik YK
    Proteomics; 2005 Aug; 5(13):3386-96. PubMed ID: 16047310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
    Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
    Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
    Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of alternative analytical techniques for the characterisation of the human serum proteome in HUPO Plasma Proteome Project.
    Li X; Gong Y; Wang Y; Wu S; Cai Y; He P; Lu Z; Ying W; Zhang Y; Jiao L; He H; Zhang Z; He F; Zhao X; Qian X
    Proteomics; 2005 Aug; 5(13):3423-41. PubMed ID: 16052619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromatofocusing fractionation and two-dimensional difference gel electrophoresis for low abundance serum proteins.
    Qin S; Ferdinand AS; Richie JP; O'Leary MP; Mok SC; Liu BC
    Proteomics; 2005 Aug; 5(12):3183-92. PubMed ID: 16035113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker discovery in breast cancer serum using 2-D differential gel electrophoresis/ MALDI-TOF/TOF and data validation by routine clinical assays.
    Huang HL; Stasyk T; Morandell S; Dieplinger H; Falkensammer G; Griesmacher A; Mogg M; Schreiber M; Feuerstein I; Huck CW; Stecher G; Bonn GK; Huber LA
    Electrophoresis; 2006 Apr; 27(8):1641-50. PubMed ID: 16550499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
    Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
    J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling protein markers associated with lymph node metastasis in prostate cancer by DIGE-based proteomics analysis.
    Pang J; Liu WP; Liu XP; Li LY; Fang YQ; Sun QP; Liu SJ; Li MT; Su ZL; Gao X
    J Proteome Res; 2010 Jan; 9(1):216-26. PubMed ID: 19894759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling of myelin proteins by 2D-gel electrophoresis and multidimensional liquid chromatography coupled to MALDI TOF-TOF mass spectrometry.
    Vanrobaeys F; Van Coster R; Dhondt G; Devreese B; Van Beeumen J
    J Proteome Res; 2005; 4(6):2283-93. PubMed ID: 16335977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversed-phase high-performance liquid chromatographic prefractionation of immunodepleted human serum proteins to enhance mass spectrometry identification of lower-abundant proteins.
    Martosella J; Zolotarjova N; Liu H; Nicol G; Boyes BE
    J Proteome Res; 2005; 4(5):1522-37. PubMed ID: 16212403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulated expression of complement factor I: a potential suppressive protein for gastric cancer identified by serum proteome analysis.
    Liu W; Liu B; Xin L; Zhang Y; Chen X; Zhu Z; Lin Y
    Clin Chim Acta; 2007 Feb; 377(1-2):119-26. PubMed ID: 17067565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derivatized cellulose combined with MALDI-TOF MS: a new tool for serum protein profiling.
    Feuerstein I; Rainer M; Bernardo K; Stecher G; Huck CW; Kofler K; Pelzer A; Horninger W; Klocker H; Bartsch G; Bonn GK
    J Proteome Res; 2005; 4(6):2320-6. PubMed ID: 16335981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic identification of serum biomarkers for head and neck cancer surveillance.
    Gourin CG; Zhi W; Adam BL
    Laryngoscope; 2009 Jul; 119(7):1291-302. PubMed ID: 19444892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of electrophoretically derived protein mass estimates as additional constraints in proteome analysis of human serum based on MS/MS analysis.
    Kim JY; Lee JH; Park GW; Cho K; Kwon KH; Park YM; Cho SY; Paik YK; Yoo JS
    Proteomics; 2005 Aug; 5(13):3376-85. PubMed ID: 16052618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling.
    Ehmann M; Felix K; Hartmann D; Schnölzer M; Nees M; Vorderwülbecke S; Bogumil R; Büchler MW; Friess H
    Pancreas; 2007 Mar; 34(2):205-14. PubMed ID: 17312459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of serum biomarkers of ovarian epithelial cancers based on 2-DE DIGE and MALDI TOF/TOF].
    Zhao Q; Duan W; Wu YM; Qian XH; Deng XH
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):754-8. PubMed ID: 19173805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of 2-D free-flow electrophoresis/RP-HPLC for proteomic analysis of human plasma depleted of multi high-abundance proteins.
    Moritz RL; Clippingdale AB; Kapp EA; Eddes JS; Ji H; Gilbert S; Connolly LM; Simpson RJ
    Proteomics; 2005 Aug; 5(13):3402-13. PubMed ID: 16052629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum proteomic variation study in patients with Crohn disease].
    Kang L; Yang ZL; Liu W; Zhang LJ; Liu SJ; Huang MJ; Li MT; Wang JP
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 May; 11(3):266-9. PubMed ID: 18478474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 98.